Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252

NCT02120976 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: JTT-252 or Placebo
DRUG: JTT-252

Sponsor

Akros Pharma Inc.